| 1 |
27779245 | Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease. | 2018 Jan |
3 |
| 2 |
24705818 | Sustained increase of PKA activity in the postcommissural putamen of dyskinetic monkeys. | 2014 Dec |
1 |
| 3 |
20850462 | Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in rats. | 2011 Feb-Mar |
1 |
| 4 |
19353703 | Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism. | 2009 May 15 |
1 |
| 5 |
19371585 | Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in rats. | 2009 May-Jun |
1 |
| 6 |
19371586 | Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats. | 2009 May-Jun |
1 |
| 7 |
17588764 | In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias. | 2007 Aug |
1 |
| 8 |
15885624 | Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. | 2005 Jun |
1 |
| 9 |
15226382 | Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys. | 2004 Nov |
1 |